Uncategorized

Sensorion Submits Clinical Trial Application for Lead Gene Therapy Candidate OTOF-GT in the UK

Sensorion a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, announced that it has submitted a first Clinical Trial Application for OTOF-GT to the UK’s Medicines and Healthcare products Regulatory Agency.

Sensorion Submits Clinical Trial Application for Lead Gene Therapy Candidate OTOF-GT in the UK Read More »

Scroll to Top